May 13, 2007
GOVERNOR CONGRATULATES MYLAN LABORATORIES ON HUGE ACQUISITION

Homegrown company becomes global leader

Contact: Lara Ramsburg, 304-558-2000

Pharmaceutical makers Mylan Laboratories Inc. and Merck KGaA on Saturday announced the signing of a definitive agreement under which Mylan will acquire Merck’s generics business for $6.7 billion, making Mylan the world’s third-largest manufacturer of generic drugs.

Canonsburg, Pa.-based Mylan Laboratories, which was founded by Milan Puskar and Don Panoz in White Sulphur Springs, W.Va., in 1961, now will employ about 10,000 and would have had 2006 combined revenues of $4.2 billion. The Mylan Pharmaceuticals division is headquartered in Morgantown, W.Va., and employs 2,000.

Gov. Joe Manchin today congratulated Mylan’s Chief Executive Officer Robert Coury and Chairman of the Board Milan Puskar on this monumental step in the company’s 46-year history. “Mike Puskar and Robert Coury have taken a bold and logical step to secure the growth of Mylan’s future,” the governor said.

“This is an amazing accomplishment which shows once again Mylan’s leadership team executing on its vision with drive and commitment, while maintaining and enhancing their leading position in the generic pharmaceutical industry,” Manchin said. “This acquisition immediately transforms Mylan from the nation’s third-largest manufacturer of generics to the world’s third-largest manufacturer. As Mylan continues to grow globally, West Virginia will remain part of its solid foundation.“I am very proud that Mylan was founded in, and remains a leading employer in, the great state of West Virginia.”

Mylan Laboratories Inc. is a leading pharmaceutical company with three principle subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc., and a controlling interest in Matrix Laboratories Limited, India. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products. For more information about Mylan, visit http://www.mylan.com.